VistaGen Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $244 | $-15 | $234 | $183 |
Gross Profit | 75 | -15 | 234 | 183 |
EBITDA | -14,926 | -14,329 | -14,959 | -14,070 |
EBIT | -15,095 | -14,495 | -15,120 | -14,227 |
Net Income | -15,095 | -13,635 | -14,089 | -12,961 |
Net Change In Cash | 244 | -15 | 234 | 183 |
Free Cash Flow | -18,846 | -10,150 | -10,280 | -10,844 |
Cash | 48,985 | 67,131 | 74,715 | 84,246 |
Basic Shares | 31,930 | 30,711 | 30,711 | 30,632 |
Annual Financials
| Values in thousands | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
Revenue | $486 | $1,064 | $-227 | $1,108 |
Gross Profit | 486 | 1,064 | -227 | 1,108 |
EBITDA | -55,338 | -32,453 | -58,736 | -47,047 |
EBIT | -55,973 | -33,021 | -59,268 | -47,759 |
Net Income | -51,418 | -29,362 | -59,247 | -47,762 |
Net Change In Cash | 486 | 1,064 | -227 | 1,108 |
Cost of Revenue | -34,973 | |||
Free Cash Flow | -42,288 | -25,874 | -49,927 | -45,456 |
Cash | 67,131 | 119,166 | 16,637 | 68,135 |
Basic Shares | 30,711 | 19,354 | 6,958 | 6,599 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.47 |
2025-03-31 | -$0.44 |
2024-12-31 | -$0.46 |
2024-09-30 | -$0.42 |
